These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12006790)

  • 1. Protective effect of a novel, potent inhibitor of poly(adenosine 5'-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis.
    Goldfarb RD; Marton A; Szabó E; Virág L; Salzman AL; Glock D; Akhter I; McCarthy R; Parrillo JE; Szabó C
    Crit Care Med; 2002 May; 30(5):974-80. PubMed ID: 12006790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
    Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
    Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, blinded, placebo-controlled trial of tissue factor pathway inhibitor in porcine septic shock.
    Goldfarb RD; Glock D; Johnson K; Creasey AA; Carr C; McCarthy RJ; Matushek M; Akhter I; Trenholme G; Parrillo JE
    Shock; 1998 Oct; 10(4):258-64. PubMed ID: 9788657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.
    Faro R; Toyoda Y; McCully JD; Jagtap P; Szabo E; Virag L; Bianchi C; Levitsky S; Szabo C; Sellke FW
    Ann Thorac Surg; 2002 Feb; 73(2):575-81. PubMed ID: 11845877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia.
    Iványi Z; Hauser B; Pittner A; Asfar P; Vassilev D; Nalos M; Altherr J; Brückner UB; Szabó C; Radermacher P; Fröba G
    Shock; 2003 May; 19(5):415-21. PubMed ID: 12744483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase.
    Mabley JG; Jagtap P; Perretti M; Getting SJ; Salzman AL; Virág L; Szabó E; Soriano FG; Liaudet L; Abdelkarim GE; Haskó G; Marton A; Southan GJ; Szabó C
    Inflamm Res; 2001 Nov; 50(11):561-9. PubMed ID: 11766996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
    Tao X; Chen X; Hou Z; Hao S; Liu B
    World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis.
    Strand OA; Leone AM; Giercksky KE; Skovlund E; Kirkebøen KA
    Crit Care Med; 1998 Sep; 26(9):1490-9. PubMed ID: 9751584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
    Cuzzocrea S; Zingarelli B; Costantino G; Sottile A; Teti D; Caputi AP
    Crit Care Med; 1999 Aug; 27(8):1517-23. PubMed ID: 10470759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest.
    Szabó G; Buhmann V; Andrási T; Stumpf N; Bährle S; Kékesi V; Hagl S; Szabó C; Juhász-Nagy A
    J Thorac Cardiovasc Surg; 2003 Sep; 126(3):651-8. PubMed ID: 14502135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicotinamide, an inhibitor of PARS activity, on gut and liver O2 exchange and energy metabolism during hyperdynamic porcine endotoxemia.
    Theisen M; Träger K; Tugtekin I; Stehr A; Ploner F; Georgieff M; Radermacher P; Matĕjovic M
    Intensive Care Med; 2001 Mar; 27(3):586-92. PubMed ID: 11355130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs.
    Albertini M; Clement MG; Lafortuna CL; Caniatti M; Magder S; Abdulmalek K; Hussain SN
    J Crit Care; 2000 Jun; 15(2):73-83. PubMed ID: 10877368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
    Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
    J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.
    Zingarelli B; Cuzzocrea S; Zsengellér Z; Salzman AL; Szabó C
    Cardiovasc Res; 1997 Nov; 36(2):205-15. PubMed ID: 9463632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock.
    Szabó A; Hake P; Salzman AL; Szabó C
    Shock; 1998 Nov; 10(5):347-53. PubMed ID: 9840650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.
    Szabó G; Bährle S; Stumpf N; Sonnenberg K; Szabó E E; Pacher P; Csont T; Schulz R; Dengler TJ; Liaudet L; Jagtap PG; Southan GJ; Vahl CF; Hagl S; Szabó C
    Circ Res; 2002 Jan; 90(1):100-6. PubMed ID: 11786525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the activation of poly (ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture?
    Baechtold F; Scott JA; Markert M; Mehta S; McCormack DG; Anglada F; Galaud D; Vaglio M; Waeber B; Feihl F
    Shock; 2001 Aug; 16(2):137-42. PubMed ID: 11508866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.
    Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C
    Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.